Raphael Hablesreiter
Overview
Explore the profile of Raphael Hablesreiter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arends C, Kopp K, Hablesreiter R, Estrada N, Christen F, Moll U, et al.
Leukemia
. 2024 May;
38(6):1440.
PMID: 38714878
No abstract available.
2.
Arends C, Kopp K, Hablesreiter R, Estrada N, Christen F, Moll U, et al.
Leukemia
. 2024 Apr;
38(6):1378-1389.
PMID: 38637689
Clonal hematopoiesis (CH) driven by mutations in the DNA damage response (DDR) pathway is frequent in patients with cancer and is associated with a higher risk of therapy-related myeloid neoplasms...
3.
Noerenberg D, Briest F, Hennch C, Yoshida K, Hablesreiter R, Takeuchi Y, et al.
J Clin Oncol
. 2023 Dec;
42(4):452-466.
PMID: 38055913
Purpose: Primary mediastinal large B-cell lymphoma (PMBCL) is a rare aggressive lymphoma predominantly affecting young female patients. Large-scale genomic investigations and genetic markers for risk stratification are lacking. Patients And...
4.
Briest F, Noerenberg D, Hennch C, Yoshida K, Hablesreiter R, Nimo J, et al.
Leukemia
. 2023 Aug;
37(11):2237-2249.
PMID: 37648814
Recent exome-wide studies discovered frequent somatic mutations in the epigenetic modifier ZNF217 in primary mediastinal B cell lymphoma (PMBCL) and related disorders. As functional consequences of ZNF217 alterations remain unknown,...
5.
Arends C, Liman T, Strzelecka P, Kufner A, Lowe P, Huo S, et al.
Blood
. 2022 Nov;
141(7):787-799.
PMID: 36441964
Clonal hematopoiesis (CH) is common among older people and is associated with an increased risk of atherosclerosis, inflammation, and shorter overall survival. Age and inflammation are major risk factors for...
6.
Arends C, Dimitriou S, Stahler A, Hablesreiter R, Strzelecka P, Stein C, et al.
Blood
. 2021 Dec;
139(10):1593-1597.
PMID: 34932794
No abstract available.
7.
Christen F, Hablesreiter R, Hoyer K, Hennch C, Maluck-Bottcher A, Segler A, et al.
Leukemia
. 2021 Nov;
36(4):1102-1110.
PMID: 34782715
To investigate clonal hematopoiesis associated gene mutations in vitro and to unravel the direct impact on the human stem and progenitor cell (HSPC) compartment, we targeted healthy, young hematopoietic progenitor...
8.
Christen F, Hoyer K, Yoshida K, Hou H, Waldhueter N, Heuser M, et al.
Blood
. 2019 Jan;
133(10):1140-1151.
PMID: 30610028
Acute myeloid leukemia with t(8;21)(q22;q22) is characterized by considerable clinical and biological heterogeneity leading to relapse in up to 40% of patients. We sequenced coding regions or hotspot areas of...
9.
Frick M, Chan W, Arends C, Hablesreiter R, Halik A, Heuser M, et al.
J Clin Oncol
. 2018 Nov;
37(5):375-385.
PMID: 30403573
Purpose: Clonal hematopoiesis of indeterminate potential (CHIP) occurs in the blood of approximately 20% of older persons. CHIP is linked to an increased risk of hematologic malignancies and of all-cause...